John Krystal, MD
Enriched profileRobert L. McNeil, Jr. Professor of Translational Research; Professor of Psychiatry, Neuroscience, and Psychology; Chair, Department of Psychiatry; Physician-in-Chief of Psychiatry, Yale New Haven Hospital · Yale University
John Krystal is Robert L. McNeil, Jr. Professor of Translational Research; Professor of Psychiatry, Neuroscience, and Psychology; Chair, Department of Psychiatry; Physician-in-Chief of Psychiatry, Yale New Haven Hospital at Yale University. OpenAlex indexes 1,034 publications with 89,336 citations (h-index 158); ClinicalTrials.gov lists 10 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Psychiatry profiles in the findmyKOL directory. Clarivate lists John Krystal as a Highly Cited Researcher (Cross-Field, 2019-2023; Psychiatry and Psychology, 2024-2025).
Data verified 14 Aug 2026
Overview
Updated 13 Oct 2026
John H. Krystal, MD, is Robert L. McNeil, Jr. Professor of Translational Research at Yale University / Yale School of Medicine, Department of Psychiatry. The public record shows 1,034 publications with 89,336 citations (h-index 158), centered on Bipolar Disorder, Schizophrenia, Depression (MDD). It also documents an investigator role on 10 registered clinical trials, industry payments reported by 13 companies, 24 NIH-funded awards (1995–2026).
- Most recent indexed publication: 2026 · Molecular psychiatry
- Top research focus: Bipolar Disorder
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 41 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Written testimony to the Connecticut General Assembly (Appropriations Committee) supporting HB-5048
An Act Adjusting the State Budget, as Chair, Department of Psychiatry, Yale University
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cga.ct.gov ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Oct 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Industry payments
Updated 13 Oct 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year202514 payments$13,058openpaymentsdata.cms.gov ↗
- Alkermes, Inc.Program year20251 payment$10,605openpaymentsdata.cms.gov ↗
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20251 payment
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI100%Fluoxetine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Oct 2026
24 NIH research awards on record, funded 1995–2026 per NIH RePORTER. The latest:
- Yale Clinical and Translational Science Award (U Component)
Yale University
FY2026$4,812,525UL1TR001863 - AMPA Receptor Components of the Antidepressant Response to Ketamine in Humans
Yale University
FY2026$834,244R01MH129371
Publications
Updated 13 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- α(2)-Adrenergic receptor modulates 5-HT(2A)-mediated behavioral effects of MDMA and psilocybin in mice.
Molecular psychiatry
Article2026 - Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies.
Molecular psychiatry
Meta-analysis2026 - Reversible alterations of brain acetate metabolism associated with alcohol consumption.
Neuropsychopharmacology
Article2026 - Central amygdala single-nucleus atlas reveals chromatin and gene transcription dynamics in human alcohol use disorder.
Nature communications
Article2026
Online presence
Updated 13 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/john-krystal-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
freedombio.co/team/dr-john-krystal
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →freedombio.co ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- Board Certified in Psychiatry
American Board of Psychiatry and Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Editorial & leadership roles
journal and society appointments- Co-Director
Yale Center for Clinical Investigation (CTSA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Director
NIAAA Center for the Translational Neuroscience of Alcohol (CTNA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Director
Clinical Neuroscience Division, VA National Center for PTSD, VA Connecticut
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Cross-Field20192020202120222023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
- Psychiatry and Psychology20242025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- 2026 Connecticut Medal of Technology (Connecticut Academy of Science and Engineering)
for the discovery of the rapid antidepressant actions of ketamine
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychology.yale.edu ↗
- Co-founder
Freedom Biosciences (rapid-acting antidepressant therapeutics)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Scientific Advisory Board member
Aligning Research to Impact Autism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Media & interviews
press, podcasts and appearances- Brave New World podcast (Evgeny Lebedev / The Standard/Acast)
"Why ketamine can solve a mental health epidemic"
2024provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →shows.acast.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tim.blog ↗
- Psychiatric Times interview
"Exploring the Future of Ketamine and Psychedelic Treatment"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatrictimes.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
Eric Velazquez, MD
Yale University
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons
Christoph Correll, MD
Charité